Cargando…

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide. Pemetrexed, a multi-target folate antagonist, has demonstrated efficacy in NSCLC histological subtypes characterized by low thymidylate synthase (TS) expression. Among many other potential targets,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Bufalo, Donatella, Desideri, Marianna, De Luca, Teresa, Di Martile, Marta, Gabellini, Chiara, Monica, Valentina, Busso, Simone, Eramo, Adriana, De Maria, Ruggero, Milella, Michele, Trisciuoglio, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198757/ https://www.ncbi.nlm.nih.gov/pubmed/25301686 http://dx.doi.org/10.1186/1476-4598-13-230

Ejemplares similares

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
por: Di Martile, Marta, et al.
Publicado: (2018)

Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
por: Di Martile, Marta, et al.
Publicado: (2016)

Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer
por: Trisciuoglio, Daniela, et al.
Publicado: (2018)

Bcl-2 Regulates HIF-1α Protein Stabilization in Hypoxic Melanoma Cells via the Molecular Chaperone HSP90
por: Trisciuoglio, Daniela, et al.
Publicado: (2010)

BCL-X(L) overexpression promotes tumor progression-associated properties
por: Trisciuoglio, Daniela, et al.
Publicado: (2017)

Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells
por: Di Martile, Marta, et al.
Publicado: (2020)

The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic target
por: Di Martile, Marta, et al.
Publicado: (2016)

The thiazole derivative CPTH6 impairs autophagy
por: Ragazzoni, Y, et al.
Publicado: (2013)

Affinity purification-mass spectrometry analysis of bcl-2 interactome identified SLIRP as a novel interacting protein
por: Trisciuoglio, D, et al.
Publicado: (2016)

Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
por: D’Aguanno, Simona, et al.
Publicado: (2018)

Synergistic enhancement of NK cell-mediated cytotoxicity by combination of histone deacetylase inhibitor and ionizing radiation
por: Son, Cheol-Hun, et al.
Publicado: (2014)

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
por: Mey, V, et al.
Publicado: (2006)

Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells
por: Yenigül, Münevver, et al.
Publicado: (2023)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells
por: Cerna, Tereza, et al.
Publicado: (2018)

Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines
por: Nannizzi, Sara, et al.
Publicado: (2009)

microRNA-378a-5p iS a novel positive regulator of melanoma progression
por: Tupone, Maria Grazia, et al.
Publicado: (2020)

Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
por: Di Martile, Marta, et al.
Publicado: (2020)

Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway
por: Hsu, Fu-Shun, et al.
Publicado: (2019)

Sequence-dependent synergistic cytotoxicity of icotinib and pemetrexed in human lung cancer cell lines in vitro and in vivo
por: Liu, Tianze, et al.
Publicado: (2019)

Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model
por: Pająk, Beata, et al.
Publicado: (2021)

Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis
por: Parrella, Edoardo, et al.
Publicado: (2022)

Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer
por: Lin, Yilin, et al.
Publicado: (2023)

Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma
por: Di Martile, Marta, et al.
Publicado: (2020)

Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy
por: Stankov, Metodi V., et al.
Publicado: (2013)

Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
por: Rikiishi, Hidemi
Publicado: (2010)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Inhibition of Histone Methyltransferase, Histone Deacetylase, and β-Catenin Synergistically Enhance the Cardiac Potential of Bone Marrow Cells
por: Yang, Jinpu, et al.
Publicado: (2017)

SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
por: Valentini, Elisabetta, et al.
Publicado: (2021)

Histone Deacetylase Inhibitors Impair the Elimination of HIV-Infected Cells by Cytotoxic T-Lymphocytes
por: Jones, Richard Brad, et al.
Publicado: (2014)

Histone deacetylases 1 and 2 restrain CD4(+) cytotoxic T lymphocyte differentiation
por: Preglej, Teresa, et al.
Publicado: (2020)

Histone Deacetylase Inhibitory and Cytotoxic Activities of the Constituents from the Roots of Sophora Pachycarpa
por: Soltani, Saba, et al.
Publicado: (2020)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Histone deacetylases as targets for antitrypanosomal drugs
por: Zuma, Aline A, et al.
Publicado: (2018)

Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer
por: Di Fazio, Pietro, et al.
Publicado: (2016)

Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
por: Mrakovcic, Maria, et al.
Publicado: (2017)

Role of autophagy and histone deacetylases in diabetic nephropathy: Current status and future perspectives
por: Khan, Sabbir, et al.
Publicado: (2016)

Histone Deacetylase 3 Regulates Adipocyte Phenotype at Early Stages of Differentiation
por: Cricrí, Dalma, et al.
Publicado: (2021)

Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1
por: Martínez-Bonet, Marta, et al.
Publicado: (2015)

Synergistic Interaction of Histone Deacetylase 6- and MEK-Inhibitors in Castration-Resistant Prostate Cancer Cells
por: Corno, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_70utdgfb7406cm6d7npf5ibnk0